Each year, OCRA honors individuals doing important and notable work in the ovarian cancer field with a research prize to help propel their future discoveries. Individuals are selected by members … Continued
As we gear up for our first ever virtual Spring Advocacy Day — which will welcome more than 200 participants, double our usual crowd! — we couldn’t help but take … Continued
Imagine, if you will, a scene from yesteryear: rows of telephone operators sitting in front of giant switchboards, lights blinking on and off in seemingly random patterns, hands working quickly … Continued
PARP inhibitors have proven to be particularly valuable in improving progression-free survival for patients with certain types of ovarian cancer. But unfortunately, these gains come at a high financial cost … Continued
February 16, 2021 President Joseph R. Biden, Jr.The White House1600 Pennsylvania Avenue, NWWashington, DC 20500 Dear Mr. President: On behalf of a broad spectrum of organizations, cancer centers, and other … Continued
Dr. Xueyang Yu, of Massachusetts Institute of Technology, is a 2021 recipient of OCRA’s Ann and Sol Mentored Investigator Award. Her project, “Macrophage Control of the Microenvironment Drives HGSOC Progression,” … Continued
We have great hope for the year ahead, and much of that is buoyed by what we accomplished, with your help, in 2020. A quick look back at the numbers… … Continued
Every 23 minutes, a woman is diagnosed with ovarian cancer in the United States. We need your help in raising awareness of this disease, and in raising critical funds for … Continued
Despite the challenges of fundraising during a global pandemic, your generous support allowed us to fund 16 top scientists at 14 esteemed medical centers across the globe. They will investigate … Continued
Registration closes on December 17, 2021. Together, we made great strides in 2020 on Capitol Hill, and we are excited to announce that we now have more OCRA Advocate Leaders … Continued
OCRA-funded researcher Anil K. Sood, M.D., lead and senior author, and Sanghoon Lee, Ph.D., first author, both at MD Anderson Cancer Center, along with colleagues, identified potential biomarkers in subgroups of … Continued
It’s hard to believe 2020 is almost over, and what a year it’s been. Despite the challenges wrought by the pandemic, we’re grateful to report that thanks to your support, OCRA grantees made great strides … Continued
Get email updates about research news, action alerts, and ways to join the fight.
